Correlation Between Madrigal Pharmaceuticals and Beam Therapeutics
Can any of the company-specific risk be diversified away by investing in both Madrigal Pharmaceuticals and Beam Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Madrigal Pharmaceuticals and Beam Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Madrigal Pharmaceuticals and Beam Therapeutics, you can compare the effects of market volatilities on Madrigal Pharmaceuticals and Beam Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Madrigal Pharmaceuticals with a short position of Beam Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Madrigal Pharmaceuticals and Beam Therapeutics.
Diversification Opportunities for Madrigal Pharmaceuticals and Beam Therapeutics
0.52 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Madrigal and Beam is 0.52. Overlapping area represents the amount of risk that can be diversified away by holding Madrigal Pharmaceuticals and Beam Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Beam Therapeutics and Madrigal Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Madrigal Pharmaceuticals are associated (or correlated) with Beam Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Beam Therapeutics has no effect on the direction of Madrigal Pharmaceuticals i.e., Madrigal Pharmaceuticals and Beam Therapeutics go up and down completely randomly.
Pair Corralation between Madrigal Pharmaceuticals and Beam Therapeutics
Given the investment horizon of 90 days Madrigal Pharmaceuticals is expected to generate 5.45 times less return on investment than Beam Therapeutics. But when comparing it to its historical volatility, Madrigal Pharmaceuticals is 1.65 times less risky than Beam Therapeutics. It trades about 0.05 of its potential returns per unit of risk. Beam Therapeutics is currently generating about 0.18 of returns per unit of risk over similar time horizon. If you would invest 2,293 in Beam Therapeutics on September 2, 2024 and sell it today you would earn a total of 444.00 from holding Beam Therapeutics or generate 19.36% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Madrigal Pharmaceuticals vs. Beam Therapeutics
Performance |
| Timeline |
| Madrigal Pharmaceuticals |
| Beam Therapeutics |
Madrigal Pharmaceuticals and Beam Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Madrigal Pharmaceuticals and Beam Therapeutics
The main advantage of trading using opposite Madrigal Pharmaceuticals and Beam Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Madrigal Pharmaceuticals position performs unexpectedly, Beam Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Beam Therapeutics will offset losses from the drop in Beam Therapeutics' long position.| Madrigal Pharmaceuticals vs. TG Therapeutics | Madrigal Pharmaceuticals vs. Terns Pharmaceuticals | Madrigal Pharmaceuticals vs. Hepion Pharmaceuticals | Madrigal Pharmaceuticals vs. Viking Therapeutics |
| Beam Therapeutics vs. Editas Medicine | Beam Therapeutics vs. Crispr Therapeutics AG | Beam Therapeutics vs. Caribou Biosciences | Beam Therapeutics vs. Verve Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Volatility Analysis module to get historical volatility and risk analysis based on latest market data.
Other Complementary Tools
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals |